Results 191 to 200 of about 3,766,051 (278)

Clevidipine for the management of hypertension in the perioperative cardiac and noncardiac surgical settings: a systematic review. [PDF]

Front Med (Lausanne)
Bottussi A, D'Andria Ursoleo J, Agosta VT, Piazza E, Mongardini E, Monaco F.   +5 more
europepmc   +1 more source

Synthesis and evaluation of isoquinolinyl and pyridinyl-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase to alleviate orofacial hyperalgesia in the rat. [PDF]

Biochem Biophys Rep
Carr D, Gunari S, Gorostiza G, Mercado M, Pavana L, Duong L, Gomez K, Salinas S, Garcia C, Tsang A, Morisseau C, Hammock BD, Pecic S, Kandasamy R.   +13 more
europepmc   +1 more source

A Network Meta-Analysis of Vasodilator Therapies in Pulmonary Hypertension Patients Undergoing Mitral Valve Replacement Surgery: Insights for Optimizing Hemodynamics. [PDF]

Clin Drug Investig
Elrosasy A, Maher A, Ramadan A, Hamam NG, Soliman M, Kamal SK, Milik BE, Shahat AA, Kamel MN, Ali AA, Hassan LA, Zabady A, Zeid MA, Abdelmottaleb W, Nassar S.   +14 more
europepmc   +1 more source

[Nitroglycerin: secular drug always current].

Arquivos brasileiros de cardiologia, 1995
openaire   +1 more source

Nitroglycerin: New concepts about an old drug [PDF]

The American Journal of Medicine, 1976
Abstract Increasing evidence has profoundly challenged previously accepted concepts about the actions and clinical uses of nitroglycerin. Traditionally, use of this agent has been contraindicated in patients with acute myocardial infarction because of its hypotensive effects, and it has had no place in the therapeutic armamentarium of heart failure or
Richard H. Helfant
semanticscholar   +4 more sources

Homicide and nitroglycerin. A case of drug interaction

Journal of Chemical Education, 1972
Examines the mysterious circumstances surrounding the death of a young woman in 1901 and the possibility that it was due to drinking nitroglycerin.
Frederick J. Di Carlo, Linda Culp Holmes
semanticscholar   +5 more sources

Influence of Formulating Factors on Drug Safety of Timed-Release Nitroglycerin Tablets

Journal of Pharmaceutical Sciences, 1971
A peroral sandwich model tablet with timed release, containing proxyphylline and nitroglycerin, was developed. One layer of the tablet constituted the rapidly disintegrating and dissolving initial phase; the other, the depot phase, was in the form of an insoluble, indigestible skeleton.
W. A. Ritschel
semanticscholar   +5 more sources

Effect of intermittent exposure and drug-free intervals on the vascular tolerance to nitroglycerin

Life Sciences, 1989
Recent reports suggest that intermittent nitroglycerin (NTG) treatment, incorporating a daily nitrate-free interval, can avoid the tolerance associated with continuous NTG therapy. This study has investigated whether an in vitro model of NTG tolerance could be used to examine the mechanisms of tolerance avoidance (by intermittent NTG exposure) and ...
Elizabeth A. Kowaluk, K Hough, Ho‐Leung Fung   +2 more
semanticscholar   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Assessment of the Drug Interaction between Intravenous Nitroglycerin and Heparin

Annals of Pharmacotherapy, 1992
OBJECTIVE: To assess whether a clinically significant interaction occurs between heparin and nitroglycerin (NTG). METHODOLOGY: Activated partial thromboplastin time (APTT) was measured in patients with unstable angina who were stabilized on intravenous NTG and heparin just prior to weaning the NTG infusion, and one and four hours after stopping the NTG.
Susan Graham, R. K. Elswick, Edgar R. Gonzalez, Holly D. Jones   +3 more
openaire   +4 more sources